Medicare Will Cover Prostate Cancer Drug

Medicare announced Thursday it will cover Dendreon’s prostate cancer drug Provenge, which has been shown to extend life for about four months for patients with late stages of the disease but costs up to $93,000.

Read more from the


Leave a Reply

Fill in your details below or click an icon to log in:

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

More From WCCO | CBS Minnesota

The Leaderboard
Good Question

Listen Live